Real-World Evidence Solutions Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Real-World 
Evidence Solutions 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  to  t h e  l a t e s t  r e p o r t  b y  I MA R C  Gr o u p ,  t i t l e d  " R e a l -W o r ld  E v i d e n c e  S o lu t i o n s  
Ma r k e t :  G l o b a l  In d u s t r y  T r e n d s ,  S h a r e ,  S i ze ,  G r o w t h ,  O p p o r t u n i ty  a n d  F o r e c a s t  
20 2 4 - 2 03 2 , "  t h e  g l ob a l  r e a l - w o r l d  e v i d en c e  so l u t i o n s  m a r k e t  s i z e  r e a c h ed  U S $  1 . 8  
B i l l i on  i n  2 02 3 .
Fac tors  A f fec t ing  the  Growth  o f  t he  Rea l - Wor ld  Ev idence  So lu t ions  Indust ry :
Report Growing  Dat a  Sources  and In tegra t ion  Techniques :
W i t h  t h e  i n c re a s i n g  d i g i t i z a t i on  o f  h e a l th c a r e  r e c o r ds  a n d  t h e  p r o l i f e ra t i o n  o f  w e a r a b l e  
Highlight and t e c h n o l o gy ,  v a s t  a mo u n ts  o f  he a l t h - r e l a t e d  da t a  a r e  b e i n g  g e n e r a t ed .  T h i s  e xp a n s i o n  a l l ow s  f o r  a  m o r e  c om p r e he n s i v e  u nd e r s t an d i n g  o f  p a t i e n t  o u t c o me s  i n  r e a l - w o r l d  
se t t i n g s .  M o r e o v e r ,  a d va n c em e n t s  i n  d a t a  i n t e g r a t i o n  te c h n o l og i e s  fa c i l i t a te  t h e  
Description me r g i n g  o f  d i v e r se  d a t a  t y p e s ,  i n c l u d i n g  e l e c t ro n i c  h e a l th  r e c o r d s  ( E H R s ) ,  i n s u r a nc e  
c l a i m s ,  an d  p a t i e n t - r ep o r te d  o u tc o m es .  
T h i s  i n t e g r a t i o n  e n ha n c e s  t h e  qu a l i t y  a n d  g r a n u l a r i t y  o f  r e a l - w o r l d  e v i d e n c e  (R W E ) ,  
ma k i n g  i t  m o r e  v a l u ab l e  f o r  h e a l t h c a r e  d e c i s i on - m a k i n g .  T h i s  ev o l u t i o n  i s  p i v o t a l  f o r  
ph a r m a ce u t i c a l  c o m pa n i e s ,  re g u l a to r y  a g e n c i es ,  an d  h e a l t h c a re  p r ov i d e r s ,  a s  i t  
en a b l e s  mo r e  i n f o r m e d  d e c i s i o ns  r e g a r d i n g  d r u g  d e v e l o p m en t ,  ma r k e t  a c c es s  
s t r a t e g i e s ,  a nd  t r e a t m e n t  a p p ro a c h e s .
Regulatory Environment and Pol icy Support:
Regu la tory  agenc ies  a re  recogniz ing  the  impor tance  o f  RWE in  
supp lement ing  randomized cont ro l led  t r ia l  (RCT)  da ta .  Th is  recogn i t ion  i s  
t rans la t ing in to  gu ide l ines  and  f rameworks tha t  encourage  the use o f  RWE 
in  the  approva l  o f  new drugs and the  expans ion  o f  ex is t ing  drug  ind ica t ions.  
Report Add i t iona l l y ,  po l ic ies  advoca t ing  for  the  adopt ion o f  EHRs and  the  
in teroperab i l i t y  o f  hea l th  data  sys tems are  encourag ing the  use  o f  RWE by 
Highlight and improv ing the  access ib i l i t y  and  qua l i t y  o f  rea l -wor ld  da ta .  Th is  regu la to ry  
suppor t  ensures  tha t  RWE con t inues to  p lay  a  c ruc ia l  ro le  in  the  ev idence 
h ierarchy ,  in f luenc ing d rug  deve lopment ,  marke t  access,  and pos t -market  
Description surve i l lance  s t ra teg ies .
Technological  Advancements in Data Analytics:
The deve lopment  and  app l i ca t ion o f  soph is t i ca ted  ana ly t ica l  too ls  and  
a lgor i thms,  inc lud ing  ar t i f i c ia l  in te l l i gence (AI )  and machine learn ing  (ML) ,  
are  enhanc ing  the  ab i l i t y  to  p rocess and ana lyze  la rge  datase ts .  These 
technolog ies  fac i l i ta te  the  ex t rac t ion o f  mean ing fu l  ins igh ts  f rom complex 
and  unst ruc tured  rea l -wor ld  da ta ,  enab l ing  more accura te  and  e f f ic ient  
ana lyses than  p rev ious ly  poss ib le .
The ab i l i t y  t o  qu ick ly  de r i ve  ac t ionab le  ins igh ts  f rom vas t  amounts  o f  da ta  is  
inva luab le  fo r  pharmaceu t ica l  compan ies ,  hea l thcare  p rov ide rs ,  and  
po l icymakers .  Th is  capab i l i t y  suppo r t s  a  w ide  a r ray  o f  app l ica t ions ,  rang ing  
f rom drug  deve lopment  and  pa t ien t  mon i to r ing  to  hea l th  economics  and  
ou tcomes research .
Report 
Request  for  a  PDF sample  o f  th is  repor t :  
Highlight and h t tps : / /www. imarcgroup .com/ rea l -wo r ld -ev idence-so lu t ions-marke t / reques tsamp le
Description
Report Description
Global  Real -World Evidence Solutions Market  Trends:
The growing in tegrat ion of  RWE wi th  d ig i ta l  hea l th  technolog ies ,  such as te leheal th  serv ices,  mobi le  heal th  
(mHeal th)  apps,  and wearable  dev ices,  for  co l lec t ing and analyz ing heal th  data in  rea l  t ime is  o f fer ing a 
more dynamic  and cont inuous ins ight  in to  pat ient  heal th  and behav ior  outs ide of  t rad i t iona l  heal thcare 
set t ings.  Dig i ta l  hea l th  technolog ies  enable the capture o f  a  vast  ar ray  o f  data po in ts ,  ranging f rom 
physio log ica l  met r ics to  pat ient - repor ted outcomes,  which can be analyzed us ing RWE methodolog ies  to  
generate more personal ized and t imely  ins ights  in to  t reatment  e f fect iveness and pat ient  adherence.  
Th is  convergence of  d ig i ta l  hea l th  and RWE opens novel  avenues for  heal thcare innovat ion,  a l lowing for  
the development  o f  more ho l is t ic  and pat ient -centered care models  that  can adapt  to  the changing needs 
and condi t ions of  pat ients  in  rea l - t ime.
View Report  TOC,  Figures and Tables :  
ht tps: / /www.imarcgroup.com/real -wor ld-evidence-solut ions-market
Breakup by Component:
• Clinical  Sett ings Data
• Claims Data
• Patient-Powered Data
• Pharmacy Data
• Others
Report 
Segmentation Breakup by Therapeutic Area:
• Oncology
• Immunology
• Neurology
• Cardiovascular  Disease
• Others
Breakup by End User:
• Pharmaceutical  and Medical  Device 
Companies
• Healthcare Payers
• Healthcare Providers
• Others
Report 
Segmentation Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Aetion Inc.
• Cl inigen Limited
• Flat i ron Health Inc. (Roche Holding AG)
• ICON plc
Competitive 
• Internat ional  Business Machines Corporat ion
Landscape • IQVIA
• Optum Inc.  (UnitedHealth Group Incorporated)
with Key 
• Oracle Corporation
Players • Parexel  International  Corporation
• PPD Inc. (Thermo Fisher Scient ifi c Inc.)
• Sas Inst i tute Inc.
• Syneos Health
What was the size of the global real-world evidence 
solutions market in 2023?
What is the expected growth rate of the global real-
world evidence solutions market during 2024-2032?
What are the key factors driving the global real-world 
evidence solutions market?
Key 
What has been the impact of COVID-19 on the global 
real-world evidence solutions market?
Questions 
What is the breakup of the global real-world evidence 
Answered in solutions market based on the component?
the Report What is the breakup of the global real-world evidence 
solutions market based on the therapeutic area?
What is the breakup of the global real-world evidence 
solutions market based on the end user?
What are the key regions in the global real-world 
evidence solutions market?
Who are the key players/companies in the global real-
world evidence solutions market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  R e a l - W o r l d  E v i d e n c e  S o l u t i o n s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  C o m p o n e n t
    6 . 1     C l i n i c a l  S e t t i n g s  D a t a
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     C l a i m s  D a t a
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     P a t i e n t - P o w e r e d  D a t a
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     P h a r m a c y  D a t a
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     O t h e r s
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
7     M a r k e t  B r e a k u p  b y  T h e r a p e u t i c  A r e a
    7 . 1     O n c o l o g y
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     I m m u n o l o g y
Table of         7 . 2 . 1  M a r k e t  T r e n d s        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     N e u r o l o g y
        7 . 3 . 1  M a r k e t  T r e n d s
Contents         7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     C a r d i o v a s c u l a r  D i s e a s e
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     O t h e r s
        7 . 5 . 1  M a r k e t  T r e n d s
        7 . 5 . 2  M a r k e t  F o r e c a s t
8     M a r k e t  B r e a k u p  b y  E n d  U s e r
    8 . 1     P h a r m a c e u t i c a l  a n d  M e d i c a l  D e v i c e  C o m p a n i e s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     H e a l t h c a r e  P a y e r s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m / rea l -w o r l d -ev ide nc e - so l u t i o ns -m
a rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: